Table 4.

Comparison of Key Variables of Octreotide Study Group With the Matched Historical Control Group

VariableOctreotide Study Group (n=51)Matched Historical Control Group (n=51)P Value
Demographics
 Sex, n (%)0.8
  Male35 (69)36 (71)
  Female16 (31)15 (29)
 Indication, n (%)1.0
  BTT26 (51)26 (51)
  DT25 (49)25 (49)
Age at reference bleed, y65 [60–71]65 [59–72]0.8
Ischemic cause, n (%)33 (65)33 (65)1.0
History of stroke, n (%)6 (12)9 (18)0.4
LVAD support and events before reference GI bleed
 LVAD support duration at reference GI bleed, d197 [66–761]190 [63–708]0.9
 Bleed before reference GI bleed, n (%)21 (41)0 (0)<0.01
Rebleeding rates
 Rebleed within 6 mo of reference GI bleed, n (%)12 (24)22 (43)0.04
  • Values are n (%) and median [interquartiles]. BTT indicates bridge-to-transplantation; DT, destination therapy; GI, gastrointestinal; and LVAD, left ventricular assist device.